Stock Price
3.62
Daily Change
0.14 4.02%
Monthly
-2.95%
Yearly
11.73%
Q1 Forecast
3.54

Acasti Pharma reported $0 in Gross Profit on Sales for its fiscal quarter ending in March of 2022.





Gross Profit On Sales Change Date
Acasti Pharma USD 0 0 Mar/2022
Addus HomeCare USD 116.71M 2.84M Sep/2025
Amarin USD 22.21M 28.15M Sep/2025
Cassava Sciences USD -3.96M 1.16M Sep/2025
Knight Therapeutics CAD 44.83M 9.96M Jun/2025
Option Care Health USD 272.9M 3.86M Sep/2025
Organigram Holdings CAD 31.84M 23.88M Sep/2025
Tilray USD 67.63M 15.62M Mar/2025